Stavudine Patent Expiration
Stavudine is used for managing HIV-1 infection. It was first introduced by Bristol Myers Squibb Co
Stavudine Patents
Given below is the list of patents protecting Stavudine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Zerit Xr |
US7135465 (Pediatric) | Sustained release beadlets containing stavudine |
Aug 18, 2023
(Expired) | Bristol Myers Squibb |
| Zerit Xr | US7135465 | Sustained release beadlets containing stavudine |
Feb 18, 2023
(Expired) | Bristol Myers Squibb |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Stavudine's patents.
Latest Legal Activities on Stavudine's Patents
Given below is the list recent legal activities going on the following patents of Stavudine.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 03 May, 2018 | US7135465 |
| Post Issue Communication - Certificate of Correction | 21 Aug, 2007 | US7135465 |
| Recordation of Patent Grant Mailed Critical
| 14 Nov, 2006 | US7135465 |
| Patent Issue Date Used in PTA Calculation Critical
| 14 Nov, 2006 | US7135465 |
| Issue Notification Mailed Critical
| 25 Oct, 2006 | US7135465 |
| Application Is Considered Ready for Issue Critical
| 18 Oct, 2006 | US7135465 |
| Dispatch to FDC | 18 Oct, 2006 | US7135465 |
| Issue Fee Payment Received Critical
| 13 Oct, 2006 | US7135465 |
| Issue Fee Payment Verified Critical
| 13 Oct, 2006 | US7135465 |
| Mail Notice of Allowance Critical
| 18 Jul, 2006 | US7135465 |
Stavudine's Family Patents
